Cited by 253Biochemical Analysis and Sensing TechniquesDiet, Metabolism, and DiseasePancreatic function and diabetes

Sucralose affects glycemic and hormonal responses to an oral glucose load

Open access
Pepino, M. Yanina, Tiemann, Courtney D., Patterson, Bruce W., Wice, Burton M., Klein, Samuel·2013·Diabetes Care

Abstract

OBJECTIVE: Nonnutritive sweeteners (NNS), such as sucralose, have been reported to have metabolic effects in animal models. However, the relevance of these findings to human subjects is not clear. We evaluated the acute effects of sucralose ingestion on the metabolic response to an oral glucose load in obese subjects. RESEARCH DESIGN AND METHODS: Seventeen obese subjects (BMI 42.3 ± 1.6 kg/m(2)) who did not use NNS and were insulin sensitive (based on a homeostasis model assessment of insulin resistance score ≤ 2.6) underwent a 5-h modified oral glucose tolerance test on two separate occasions preceded by consuming either sucralose (experimental condition) or water (control condition) 10 min before the glucose load in a randomized crossover design. Indices of β-cell function, insulin sensitivity (SI), and insulin clearance rates were estimated by using minimal models of glucose, insulin, and C-peptide kinetics. RESULTS: Compared with the control condition, sucralose ingestion caused 1) a greater incremental increase in peak plasma glucose concentrations (4.2 ± 0.2 vs. 4.8 ± 0.3 mmol/L; P = 0.03), 2) a 20 ± 8% greater incremental increase in insulin area under the curve (AUC) (P < 0.03), 3) a 22 ± 7% greater peak insulin secretion rate (P < 0.02), 4) a 7 ± 4% decrease in insulin clearance (P = 0.04), and 5) a 23 ± 20% decrease in SI (P = 0.01). There were no significant differences between conditions in active glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, glucagon incremental AUC, or indices of the sensitivity of the β-cell response to glucose. CONCLUSIONS: These data demonstrate that sucralose affects the glycemic and insulin responses to an oral glucose load in obese people who do not normally consume NNS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-2221

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pepino, M. Y., Tiemann, C. D., Patterson, B. W., Wice, B. M., & Klein, S.
Affiliations
  • Washington University in St. Louis (US)
  • Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri
Corresponding author
Klein, Samuel
Venue
Diabetes Care
Published
2013-08-13
Volume
36
Issue
9
Pages
2530-2535
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2111548886
Cited by
253
References
34
Citations by year
2026: 19 · 2025: 17 · 2024: 23 · 2023: 17 · 2022: 16 · 2021: 15 · 2020: 36 · 2019: 17 · 2018: 26 · 2017: 25 · 2016: 17 · 2015: 12 · 2014: 6 · 2013: 6 · 2012: 1
FWCI
12.63
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (KL2TR000450, UL1TR000448, DK56341, TR000448)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK37948, DK56341, DK088126, R01DK088126, R01DK037948, P30DK056341, P30DK020579)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
sucralose, artificial sweeteners, oral glucose tolerance, glycemic response, insulin secretion, insulin sensitivity, insulin clearance, beta-cell function, obesity, glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, glucagon, insulin resistance
MeSH terms
Adult, Blood Glucose, Female, Glucose Tolerance Test, Humans, Insulin, Male, Obesity, Sucrose, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review